The alleged lack of efficacy of antidepressants in non-severe depression: a myth debunked, Acta Psychiatr Scand, vol.137, pp.447-449, 2018. ,
Initial severity of major depression and efficacy of new generation antidepressants: individual participant data meta-analysis, Acta Psychiatr Scand, vol.137, pp.450-458, 2018. ,
Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis, Lancet, vol.7, pp.1357-1366, 2018. ,
The citalopram CIT-MD-18 pediatric depression trial: deconstruction of medical ghostwriting, data mischaracterisation and academic malfeasance, Int J Risk Saf Med, vol.28, pp.33-43, 2016. ,
Selective publication of antidepressant trials and its influence on apparent efficacy, N Engl J Med, vol.358, pp.252-260, 2008. ,
Empirically derived criteria cast doubt on the clinical significance of antidepressant-placebo differences, Contemp Clin Trials, vol.43, pp.60-62, 2015. ,
Meta-analyses with industry involvement are massively published and report no caveats for antidepressants, J Clin Epidemiol, vol.70, pp.155-163, 2016. ,
Antidepressants' black-box warning-10 years later, N Engl J Med, vol.371, pp.1666-1668, 2014. ,
Antidepressants and suicide: risk-benefit conundrums, J Psychiatry Neurosci, vol.28, pp.331-337, 2003. ,
QTc interval prolongation associated with citalopram overdose: a case report and literature review, Clin Neuropharmacol, vol.24, pp.158-162, 2001. ,
A comparative study of QT prolongation with serotonin reuptake inhibitors, Psychopharmacology, vol.234, pp.3075-3081, 2017. ,
Hepatic effects of duloxetine-I: non-clinical and clinical trial data, Curr Drug Saf, 2009. ,
, Curr Drug Saf, vol.3, pp.132-142, 2008.
, Silver Spring (MD): US Food and Drug Administration, US Food and Drug Administration, 2011.
Towards better patient care: drugs to avoid in 2018, Prescrire Int, vol.27, pp.107-111, 2018. ,
Selective serotonin reuptake inhibitors and risk for major congenital anomalies, Obstet Gynecol, vol.118, pp.111-120, 2011. ,
Sex differences in reported adverse drug reactions of Selective Serotonin Reuptake Inhibitors, Drug Saf, vol.41, pp.677-683, 2018. ,
Declines in unintended pregnancy in the United States, N Engl J Med, vol.374, pp.843-852, 2008. ,
Comparing watchful waiting with antidepressants for the management of subclinical depression symptoms to mildmoderate depression in primary care: a systematic review, Fam Pract, vol.34, pp.639-648, 2017. ,
Long-term effectiveness and cost-effectiveness of cognitive behavioural therapy as an adjunct to pharmacotherapy for treatmentresistant depression in primary care: follow-up of the CoBalT randomised controlled trial, Lancet Psychiatry, vol.3, pp.137-144, 2016. ,
Cost and Outcome of Behavioural Activation versus Cognitive Behavioural Therapy for Depression (COBRA): a randomised, controlled, non-inferiority trial, Lancet, vol.388, pp.871-880, 2016. ,
Patient preference for psychological vs pharmacologic treatment of psychiatric disorders: a meta-analytic review, J Clin Psychiatry, vol.7, pp.595-602, 2013. ,
Effect of psychotherapy for depression on quality of life: meta-analysis, Br J Psychiatry, vol.209, pp.460-468, 2016. ,
Psychological therapies versus antidepressant medication, alone and in combination for depression in children and adolescents, Cochrane Database Syst Rev, issue.11, p.8324, 2014. ,
Comparative benefits and harms of second generation antidepressants and cognitive behavioral therapies in initial treatment of major depressive disorder: systematic review and metaanalysis, BMJ, vol.351, p.6019, 2015. ,
Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: a STAR*D report, Am J Psychiatry, vol.164, pp.739-752, 2007. ,
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 2. Psychological treatments, Can J Psychiatry, vol.61, pp.524-539, 2016. ,